Back
Regional Management Vs. Nektar Therapeutics Industry Stock Comparison
Buy
85
RM
Regional Management
Last Price:
$37.70
Seasonality Move:
-2.51%
Buy
62
NKTR
Nektar Therapeutics
Last Price:
$27.39
Seasonality Move:
6.79%
Buy
85
Regional Management (RM)
is a Buy
Is Regional Management a Buy, Sell or Hold?
-
The current Regional Management [RM] share price is $37.62. The Score for RM is 85, which is 70% above its historic median score of 50, and infers lower risk than normal.
-
RM is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Buy
62
Nektar Therapeutics (NKTR)
is a Buy
Is Nektar Therapeutics a Buy, Sell or Hold?
-
The current Nektar Therapeutics [NKTR] share price is $27.26. The Score for NKTR is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
-
NKTR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
RM Stock Price Chart
What is Regional Management's stock price today?
-
The Regional Management share price today is $37.62Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RM is experiencing selling pressure, which indicates risk of future bearish movement.
NKTR Stock Price Chart
What is Nektar Therapeutics's stock price today?
-
The Nektar Therapeutics share price today is $27.26Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NKTR is experiencing slight selling pressure.
RM Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 9.31 | Buy |
Relative Strength Index (14 RSI): | 71.5 | Buy |
Chaikin Money Flow: | -36993 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (31.62 - 35.92) | Buy |
Bollinger Bands (100): | (27.81 - 33.45) | Buy |
NKTR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.04 | Buy |
Relative Strength Index (14 RSI): | 66.02 | Buy |
Chaikin Money Flow: | -23288 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (22.49 - 25.51) | Buy |
Bollinger Bands (100): | (8.3 - 22.66) | Buy |
RM Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 36.45 | Buy |
20-day SMA: | 34.11 | Buy |
50-day SMA: | 31.72 | Buy |
200-day SMA: | 31.67 | Buy |
8-day EMA: | 35.67 | Buy |
20-day EMA: | 26.94 | Buy |
50-day EMA: | 15.1 | Buy |
200-day EMA: | 4.57 | Buy |
NKTR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 24.13 | Buy |
20-day SMA: | 23.8 | Buy |
50-day SMA: | 20.82 | Buy |
200-day SMA: | 15.1 | Buy |
8-day EMA: | 24.9 | Buy |
20-day EMA: | 23.86 | Buy |
50-day EMA: | 21.15 | Buy |
200-day EMA: | 16.63 | Buy |
Regional Management Earnings Growth & RM Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.42 per share, an increase next quarter of $0.49 per share, an increase this year of $0.52 per share, and an increase next year of $2.06 per share.
Nektar Therapeutics Earnings Growth & NKTR Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.22 per share, a decrease next quarter of $0.01 per share, an increase this year of $2.16 per share, and a decrease next year of $1.84 per share.
Regional Management Technical Analysis
Aug 4 | Aug 5 | Aug 6 | Aug 7 | Aug 8 | Aug 11 | Aug 12 | Aug 13 | Aug 14 | Aug 15 | |
---|---|---|---|---|---|---|---|---|---|---|
Aug | ||||||||||
04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Nektar Therapeutics Technical Analysis
Aug 4 | Aug 5 | Aug 6 | Aug 7 | Aug 8 | Aug 11 | Aug 12 | Aug 13 | Aug 14 | Aug 15 | |
---|---|---|---|---|---|---|---|---|---|---|
Aug | ||||||||||
04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |